Key result
Gallant ICDs integrate Bluetooth communication to advance device connectivity and patient interface.
Why the study?
To review the evolution of implantable cardiac device communication up to recent advances and examine the integration of Bluetooth communication using the Gallant family of devices into modern healthcare.
Answers are grounded in this paper and cite their sources.
This review highlights the evolution of implantable defibrillators, focusing on the integration of Bluetooth communication in the Gallant™ family of devices to improve patient interface and clinical practice.
Implantable cardiac defibrillators have revolutionized the way we prevent sudden cardiac death via arrhythmias. The addition of cardiac resynchronization pacing to defibrillators has broadened that treatment to include patients with heart failure and reduced ejection fraction. As with all technology, new devices and platforms expand the capabilities and interface with patients across the world. This review discusses the evolution from the initial modalities and methods of communication of implantable devices up to the most recent advances in implantable defibrillators and their integration into patient lives and clinical practice. This review is focused on the integration of Bluetooth communication into modern healthcare with the Gallant™ family of devices, the first branded launch by Abbott Laboratories.
No takes yet. Share an insight, caveat, or question.
Corbisiero et al. (2022) conducted a review in Arrhythmias and heart failure with reduced ejection fraction. Gallant™ family of devices was evaluated. The Gallant family of implantable defibrillators integrates Bluetooth communication to advance device connectivity and patient interface in modern healthcare.
Synapse has enriched 10 related papers. Consider them for comparative context: